Proposed and Final FDA Rules: What’s Left in 2017
By Zachary Brennan -
Published 08 August 2017
The US Food and Drug Administration (FDA) is planning to release seven proposed rules and six final rules to close out 2017, according to an updated list of Department of Health and Human Services rulemakings.
Categories: News, US, FDA, Biologics and biotechnology, Drugs, Medical Devices, Regulatory intelligence, Regulatory strategy
Tags: FDA rulemakings, biologics manufacturing inspections, de novo, medical device rulemakings